journal article·2021-01Open access

PEG-interpenetrated genipin-crosslinked dual-sensitive hydrogel/nanostructured lipid carrier compound formulation for topical drug administration

Qijun Li, Shiqiang Gong, Weifan Yao, Yibin Yu, Chao Liu, Renjun Wang, Hao Pan, Minjie Wei

Abstract

PEG-interpenetrated dual-sensitive hydrogels that load nano lipid carrier (NLC) were researched and developed for topical drug administration. Natural antioxidant α-lipoic acid (ALA) was selected as our model drug. The α-lipoic acid (ALA) nano lipid carrier was successfully prepared by hot melt emulsification and ultrasonic dispersion method, and the physicochemical properties of the nano lipid carrier were investigated, including morphology, particle distribution, polydispersity coefficient, zeta potential and encapsulation efficiency. Carboxymethyl chitosan and poloxamer 407 contributed to pH- and temperature-sensitive properties in the hydrogel, respectively. Natural non-toxic cross-linking agent genipin reacted with carboxymethyl chitosan to form the hydrogel. Poly ethylene glycol (PEG), a polymer compound with good water solubility and biocompatibility, interpenetrated the hydrogel and influenced the mechanical strength and drug release behaviour. FI-IR test verified the successful synthesis of the hydrogel. The rheological parameters indicated that the mechanical strength of the hydrogel was positively correlated with the amount of PEG, and the in vitro dissolution profiles demonstrated that the increasement of PEG could accelerate the drug release rate. The compatibility of the drug delivery system was verified with cells and mice model. Topical delivery of ALA in solution, NLC and NLC-gel was investigated in-vitro.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Biochemical Acid Research Studies · Hydrogels: synthesis, properties, applications · Advancements in Transdermal Drug Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Pharmacology, School of Pharmacy, China Medical University, Shenyang, China

State Key Laboratory of Rare Earth Resource Utilization, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, China

Liaoning Medical Diagnosis and Treatment Center, Shenyang, China

School of Pharmacy, Liaoning University, Shenyang, China

Funding

Liaoning Province Scientific Research Foundation

References (48)

Show source-provided references
1. 10.3390/ijms1303398810.3390/ijms13033988 ↗
2. 10.1016/j.freeradbiomed.2007.02.03310.1016/j.freeradbiomed.2007.02.033 ↗
3. 10.1016/j.jnutbio.2010.05.00810.1016/j.jnutbio.2010.05.008 ↗
4. 10.3109/10717544.2013.84643510.3109/10717544.2013.846435 ↗
5. 10.1016/j.cryobiol.2020.04.00610.1016/j.cryobiol.2020.04.006 ↗
6. 10.1016/j.ejps.2019.10504210.1016/j.ejps.2019.105042 ↗
7. 10.1016/j.mito.2020.02.01110.1016/j.mito.2020.02.011 ↗
8. 10.1016/j.ejpb.2020.05.03210.1016/j.ejpb.2020.05.032 ↗
9. 10.1517/17425247.2015.99241310.1517/17425247.2015.992413 ↗
10. 10.3109/03639045.2012.75390110.3109/03639045.2012.753901 ↗
11. 10.1208/s12249-009-9193-610.1208/s12249-009-9193-6 ↗
12. 10.1016/j.ajps.2015.11.05310.1016/j.ajps.2015.11.053 ↗
13. 10.1080/17425247.2016.120105910.1080/17425247.2016.1201059 ↗
14. 10.1016/j.nano.2015.09.00410.1016/j.nano.2015.09.004 ↗
15. 10.1016/j.jconrel.2015.05.28110.1016/j.jconrel.2015.05.281 ↗
16. 10.1016/j.colsurfb.2013.08.03210.1016/j.colsurfb.2013.08.032 ↗
17. 10.1016/j.tifs.2011.08.00310.1016/j.tifs.2011.08.003 ↗
18. 10.1016/j.ijbiomac.2018.03.11710.1016/j.ijbiomac.2018.03.117 ↗
19. 10.1016/j.colsurfb.2018.03.01510.1016/j.colsurfb.2018.03.015 ↗
20. 10.1021/acsbiomaterials.9b0180010.1021/acsbiomaterials.9b01800 ↗
21. 10.1016/j.ijbiomac.2017.05.13210.1016/j.ijbiomac.2017.05.132 ↗
22. 10.1016/j.ejpb.2009.07.00810.1016/j.ejpb.2009.07.008 ↗
23. 10.1016/S0169-409X(01)00203-410.1016/S0169-409X(01)00203-4 ↗
24. 10.1016/j.progpolymsci.2008.07.00510.1016/j.progpolymsci.2008.07.005 ↗
25. 10.1016/j.colsurfb.2017.12.05410.1016/j.colsurfb.2017.12.054 ↗
26. 10.1039/C5RA04448K10.1039/C5RA04448K ↗
27. 10.1016/j.colsurfb.2015.03.02010.1016/j.colsurfb.2015.03.020 ↗
28. 10.1016/j.jmbbm.2014.03.01010.1016/j.jmbbm.2014.03.010 ↗
29. 10.1039/c3tb21509a10.1039/c3tb21509a ↗
30. 10.1016/j.carbpol.2016.03.07910.1016/j.carbpol.2016.03.079 ↗
31. 10.1016/j.carbpol.2015.03.03310.1016/j.carbpol.2015.03.033 ↗
32. 10.1016/j.ijbiomac.2014.09.02110.1016/j.ijbiomac.2014.09.021 ↗
33. 10.1016/j.jconrel.2014.10.00110.1016/j.jconrel.2014.10.001 ↗
34. 10.1039/C6RA08563F10.1039/C6RA08563F ↗
35. 10.1016/j.ijbiomac.2019.06.18410.1016/j.ijbiomac.2019.06.184 ↗
36. 10.1016/j.carbpol.2018.06.03410.1016/j.carbpol.2018.06.034 ↗
37. 10.1016/j.cej.2014.01.06510.1016/j.cej.2014.01.065 ↗
38. 10.1016/j.polymdegradstab.2019.10906710.1016/j.polymdegradstab.2019.109067 ↗
39. 10.1039/C4RA13581D10.1039/C4RA13581D ↗
40. 10.1038/s41563-019-0458-510.1038/s41563-019-0458-5 ↗
41. 10.1016/j.biomaterials.2019.01.04710.1016/j.biomaterials.2019.01.047 ↗
42. 10.1016/j.ajps.2018.08.00210.1016/j.ajps.2018.08.002 ↗
43. 10.1016/j.colsurfa.2017.06.08310.1016/j.colsurfa.2017.06.083 ↗
44. 10.1038/aps.2010.12510.1038/aps.2010.125 ↗
45. 10.1080/00914037.2016.121753410.1080/00914037.2016.1217534 ↗
46. 10.1039/C7CP01838J10.1039/C7CP01838J ↗
47. 10.1016/j.ijpharm.2014.11.04310.1016/j.ijpharm.2014.11.043 ↗
48. 10.1016/j.jconrel.2004.02.00210.1016/j.jconrel.2004.02.002 ↗